EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1

Nicole Y Farhat, Derek Alexander iD, Kyli McKee iD, James Iben, Jorge L Rodriguez-Gil iD, Christopher A Wassif, Niamh X Cawley iD, William E Balch, Forbes D Porter iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nicole Y Farhat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, B…. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type C, Sterol O-Acyltransferase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Together Strong Foundation, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niemann-Pick disease type C1 (NPC1) is a lysosomal disorder due to impaired intracellular cholesterol transport out of the endolysosomal compartment. Marked heterogeneity has been observed in individuals with the same NPC1 genotype, thus suggesting a significant effect of modifier genes. Prior work demonstrated that decreased SOAT1 activity decreased disease severity in an NPC1 mouse model. Thus, we hypothesized that a polymorphism associated with decreased SOAT1 expression might influence the NPC1 phenotype. Phenotyping and genomic sequencing of 117 individuals with NPC1 was performed as part of a Natural History trial. Phenotyping included determination of disease severity and disease burden. Significant clinical heterogeneity is present in individuals homozygous for the NPC1I1061T variant and in siblings. Analysis of the SOAT1 polymorphism, rs1044925 (A>C), showed a significant association of the C-allele with earlier age of neurological onset. The C-allele may be associated with a higher Annualized Severity Index Score as well as increased frequency of liver disease and seizures. A polymorphism associated with decreased expression of SOAT1 appears to be a genetic modifier of the NPC1 phenotype. This finding is consistent with prior data showing decreased phenotypic severity in Npc1-/-:Soat1-/- mice and supports efforts to investigate the potential of SOAT1 inhibitors as a potential therapy for NPC1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Niemann-Pick Disease, Type CSterol O-AcyltransferaseHumansMaleFemaleNiemann-Pick C1 ProteinChildPolymorphism, Single NucleotideAnimalsMicePhenotypeAdolescentChild, PreschoolGenes, ModifierAdultAllelesSeverity of Illness IndexGenotypeIntracellular Signaling Peptides and ProteinsYoung Adult

Stichwörter der Autor:innen

ACAT1NPC1Niemann-Pick diseaseSOAT1genetic modifiersneurodegenerationsterol O-acyltransferase 1type C1

Substanzen

Sterol O-Acyltransferasesterol O-acyltransferase 1Niemann-Pick C1 ProteinNPC1 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
  • Molecular Genomics Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
  • Division of Medical Genetics, Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Palo Alto, CA 94304, USA.
  • Department of Molecular Medicine, Scripps Research, La Jolla, CA 92037, USA.

ORCID-Profile: Derek Alexander, Kyli McKee, Jorge L Rodriguez-Gil, Niamh X Cawley, Forbes D Porter

Förderung

  • Intramural NIH HHS
  • Together Strong Foundation
  • NIA NIH HHS
  • Ara Parseghian Medical Research Fund
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NICHD NIH
  • Ara Parseghian Medical Research Foundation

Zitieren

APA

Farhat, N. Y., Alexander, D., McKee, K., Iben, J., Rodriguez-Gil, J. L., Wassif, C. A., Cawley, N. X., Balch, W. E., & Porter, F. D. (2024). Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084217

Vancouver

Farhat NY, Alexander D, McKee K, Iben J, Rodriguez-Gil JL, Wassif CA, et al. Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084217

BibTeX
@article{Farhat2024,
  author = {Farhat, Nicole Y and Alexander, Derek and McKee, Kyli and Iben, James and Rodriguez-Gil, Jorge L and Wassif, Christopher A and Cawley, Niamh X and Balch, William E and Porter, Forbes D},
  title = {Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084217}
}
Kostenlos starten →